End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
89,700 KRW | -4.27% | +9.26% | +76.92% |
Jul. 04 | HLB Stock Soars Amid FDA Re-Approval Efforts for Liver Cancer Drug | MT |
Jun. 25 | HLB Co., Ltd. announced that it expects to receive KRW 33 billion in funding from F&F Co., Ltd | CI |
- Stock Market
- Equities
- A028300 Stock
- Charts HLB Co., Ltd.
- Total Return chart